Deval Patel
Nurse Practitioner · Lansdale, PANPI 1962839340
Payments from drug & device makers
Across 386 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$902
- GSK$708
- Amgen$664
- Bayer$644
- AstraZeneca$552
- Boehringer Ingelheim$503
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,275100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $902 |
| GSK | 34 | $708 |
| Amgen | 45 | $664 |
| Bayer | 41 | $644 |
| AstraZeneca(2 entities) | 35 | $552 |
| Boehringer Ingelheim | 24 | $503 |
| AbbVie | 18 | $396 |
| Lilly USA, LLC | 21 | $386 |
| Abbott | 19 | $347 |
| Exact Sciences | 12 | $260 |
| Novartis | 12 | $246 |
| Shield Therapeutics Inc | 7 | $229 |
| Sanofi-aventis U.S. LLC | 10 | $190 |
| Dexcom, Inc. | 3 | $174 |
| Phathom Pharmaceuticals, Inc. | 7 | $152 |
| Pfizer | 7 | $145 |
| Johnson & Johnson | 7 | $139 |
| Merck | 9 | $126 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $119 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $77 |
| Astellas Pharma US Inc | 2 | $54 |
| Clarus Therapeutics Inc. | 2 | $43 |
| Seqirus USA Inc | 2 | $37 |
| Insulet Corporation | 1 | $28 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Stryker | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Cequr Corporation | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| Endogastric Solutions, Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,275 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Synjardy XrEmpagliflozin/Metformin Hcl | 166 | $144,611 |
| JanuviaSitagliptin Phosphate | 110 | $85,199 |
| TradjentaLinagliptin | 81 | $69,078 |
| JardianceEmpagliflozin | 57 | $68,944 |
| MounjaroTirzepatide | 38 | $49,089 |
| EliquisApixaban | 25 | $40,214 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 49 | $37,475 |
| FarxigaDapagliflozin Propanediol | 38 | $36,515 |
| LinzessLinaclotide | 24 | $32,431 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $24,328 |
| ProliaDenosumab | 14 | $24,025 |
| InvokanaCanagliflozin | 25 | $21,395 |
| Xigduo XrDapaglifloz Propaned/Metformin | 24 | $19,026 |
| SynjardyEmpagliflozin/Metformin Hcl | 13 | $18,341 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $15,307 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimSynjardy Xr, Tradjenta, Jardiance, Trijardy Xr, Synjardy | $503 | $338,450366 claims |
| MerckJanuvia, Janumet | $126 | $100,507126 claims |
| Lilly USA, LLCMounjaro | $386 | $49,08938 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix | $708 | $40,50875 claims |
| PfizerEliquis | $145 | $40,21425 claims |
| AstraZenecaFarxiga | $552 | $36,51538 claims |
| AbbVieLinzess, Synthroid | $396 | $34,15052 claims |
| AmgenProlia | $664 | $24,02514 claims |
| Johnson & JohnsonInvokana | $139 | $21,39525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Lansdale
- Maria CornacchioneLansdale$12K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.